Species comparison of adenosine receptor subtypes in brain and testis

Neurochemical Research

Volumn 33, Issue 5, 2008, Pages 852-860

  Giannaccini, Gino ^a   Betti, Laura ^a   Palego, Lionella ^a   Fabbrini, Laura ^a   Schmid, Lara ^a   Castagna, Maura ^a   Giusti, Laura ^a   Mascia, Giovanni ^a   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adenosine receptors; Brain; Species; Testis

Indexed keywords

4 AMINOBENZYL 5' N METHYLCARBOXAMIDOADENOSINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; AMIDE; IODINE 125; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CATTLE; HUMANS; MALE; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SPECIES SPECIFICITY; TESTIS;

BOVINAE; RATTUS;

EID: 41049087612     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9525-4     Document Type: Article

References (49)

1. Burnstock G (2006) Purinergic signalling. Br J Pharmacol 147(Suppl 1):S172-S181
2. Rudolphi KA, Shubert P, Parkinson FE et al (1992) Neuroprotective role of adenosine in cerebral ischemia. Trends Pharmacol Sci 13:439-445
3. Stone TW (2005) Adenosine neurodegeneration and neuroprotection. Neurol Res 27:161-168
4. Boison D (2005) Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11:25-36
5. Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463-484
6. Giniatullin RA, Sokolova EM (1998) ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors. Br J Pharmacol 124:838-844
7. Linden JM (1999) Purinergic system. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD (eds) Basic neurochemistry, molecular, cellular, and medical aspects. Lippincott Williams and Wilkins, Philadelphia
8. Knott TK, Marrero HG, Fenton RA et al (2007) Endogenous adenosine inhibits CNS terminal Ca(2+) currents and exocytosis. J Cell Physiol 210:309-314
9. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the Central Nervous System. Annu Rev Neurosci 24:31-55
10. Sebastião AM, Ribeiro JA (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21:341-346
11. Fredholm BB, Ijzerman AP, Jacobson KA et al (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552
12. Englert M, Quitterer U, Klotz KN (2002) Effector coupling of stably transfected human A3 adenosine receptors in CHO cells. Biochem Pharmacol 64:61-65
13. Akbar M, Okajima F, Tomura H et al (1994) A single species of A1 receptors expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release. Mol Pharmacol 45:1036-1042
14. Miller KJ, Hoffman BJ (1994) Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J Biol Chem 269:27351-27356
15. Abbracchio MP, Brambilla R, Ceruti S et al (1995) G protein dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol Pharmacol 48:1038-1045
16. Bauer A, Holschbach MH, Meyer PT et al (2003) In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography. Neuroimage 19:1760-1769
17. Rebola N, Pinheiro PC, Oliveira CR et al (2003) Subcellular localization of adenosine A(1) receptors in nerve terminals and synapses of the rat hippocampus. Brain Res 987:49-58
18. Cunha RA, Milusheva E, Vizi ES et al (1994a) Excitatory and inhibitory effects of A1 and A2a adenosine receptor activation on the electrically-evoked [3H]-acetylcholine release from different areas of the rat hippocampus. J Neurochem 63:207-214
19. Martinez-Mir MI, Probst A, Palacios JM (1991) Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 42:697-706
20. Kessey K, Mogul DJ (1998) Adenosine A2 receptors modulate hippocampal synaptic transmission via a cyclic-AMP-dependent pathway. Neuroscience 84:59-69
21. Svenningsson P, Hall H, Sedvall G, Fredholm BB (1997) Distribution of adenosine receptors in the postmortem human brain: an extended autoradiography study. Synapse 27:322-355
22. Zhou QY, Li C, Olah ME et al (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436
23. Rivkees SA, Thevananther S, Hao H (2000) Are A3 adenosine receptors expressed in the brain? Mol Neurosci 11:1025-1030
24. 3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci 19:184-191
25. 3 receptor (ADORA3) gene. Neurosci Res 29:73-79
26. Zhu CB, Steiner JA, Munn JL et al (2007) Rapid stimulation of presynaptic serotonin transport by A3 adenosine receptors. J Pharmacol Exp Ther 322:332-340
27. 2B receptors from rat, guinea pig and dog. Eur J Pharmacol 475:79-84
28. 3 adenosine receptors. Biochem Pharmacol 65:1675-1684
29. Svenningsson P, Le Moine C, Fisone G et al (1999) Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59:355-396
30. Mazzoni MR, Buffoni RS, Giusti L et al (1995) Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes. J Recept Signal Transduct Res 15:905-929
31. 125I-4- aminobenzyl-5′-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor. Mol Pharmacol 45:978-982
32. Peterson GL (1977) A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal Biochem 83:356-366
33. Mc Pherson GA (1985) Kinetic, Ebda, Ligand, Lowry, A collection of radioligand binding analysis programs. Biosoft, Cambridge
34. 50) of an enzyme reaction. Biochem Pharmacol 22:3099-3108
35. Ferkany JW, Valentine HL, Stone GA et al (1986) Adenosine A1 receptors in mammalian brain: species differences in their interactions with agonists and antagonists. Drug Dev Res 9:85-93
36. Maemoto T, Finlayson K, Olverman HJ et al (1997) Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Br J Pharmacol 122:1202-1208
37. Kull B, Arslan G, Nilsson C et al (1999) Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Biochem Pharmacol 57:65-75
38. Olah ME, Stiles GL (2000) The role of receptor structure in determining adenosine receptor activity. Pharmacol Ther. 85:55-75
39. Nanoff C, Mitterauer T., Roka F, Hohenegger M, Freissmuth M (1995) Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane Protein that stabilizes the association of the receptor/G protein complex. Mol Pharmacol 48:806-817
40. Kull B, Svenningsson P, Hall H, Fredholm BB (2000) GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain. Neuropharmacol 39:2374-2380
41. Pauwels PJ, Tardif S, Wurch T et al (2000) Facilitation of constitutive alpha (2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism. J Pharmacol Exp Ther 292:654-663
42. Rios CD, Jordan BA, Gomes I et al (2001) G protein coupled receptor dimerization: modulation of receptor function. Pharmacol Ther 92:71-87
43. Limbird LE (2004) The receptor concept: a continuing evolution. Mol Interv 4:326-336
44. Christofi FL, Zhang H, Yu JG et al (2001) Differential gene expression of adenosine A1, A2A, A2b, and A3 receptors in the human enteric nervous system. J Comp Neurol 439:46-64
45. Castillo CA, Albasanz JL, Fernandez M et al (2007) Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells. Neurochem Res 32:1056-1070
46. 125I]AB-MECA) labels multiple adenosine receptor subtypes in rat brain. Brain Res 745:10-20
47. Salvatore CA, Jacobson MA, Taylor HE et al (1993) Molecular cloning and characterization of the human A3 adenosine receptor. Proc Natl Acad Sci USA 90:10365-10369
48. Ciruela F, Ferre' S, Casado V, Cortés A, Cunha RA, Lluis C, Franco R (2006) Heterodimeric adenosine receptors: a device to regulate neurotransmitter release. Cell Mol Life Sci 63:2427-2431
49. Franco R, Ferré S, Agnati L, Torvinen M, Ginés S, Hillion J, Casado' V, Lledo' P, Zoli M, Lluis C, Fuxe K (2000) Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology 23:S50-S59